{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:18:45Z","timestamp":1787635125079,"version":"build-2736575974"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intrathecal immunoglobulin G synthesis (ITGS) is important for MS diagnosis. Oligoclonal bands (OCB) have demonstrated sensitivity and specificity, but their complexity necessitates their analysis in specialized laboratories. Measuring the kappa free light chain index emerged as an automated and reproducible alternative and was incorporated as an alternative to OCB in the 2024 McDonald criteria. However, establishing the optimal cut-off for predicting MS diagnosis in patients with clinically isolated syndrome (CIS) is needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included 391 patients with CIS recruited between 2017 and 2022 who were followed for at least three years. Cerebrospinal fluid and serum samples were analyzed for OCB and the kappa index. Sensitivity, specificity, positive and negative predictive values were calculated for multiple kappa index cut-offs (6.1\u201320) and compared with OCB, the IgG index, and Reiber formulae. Subgroup analyses were performed according to CIS topography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A cut-off value of 15, with OCB assessment in cases with lower values, gave the best results in the total cohort, with sensitivity and specificity higher than 90%. However, subgroup analysis revealed two patterns depending on CIS location. In all locations except the optic nerve, Reiber formulae gave excellent results, comparable to those of OCB. Conversely, in patients with optic neuritis, Reiber formulae and the kappa index gave low specificity. The best strategy for these patients was a kappa index cut-off value of 15, with OCB assessment for lower values, or OCB alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The optimal semiquantitative method for detecting kappa intrathecal synthesis for predicting MS in patients with CIS depends on CIS topography. A positive value for Reiber formulae or a cut-off of 6.1 provides diagnostic performance comparable to OCB in non-optic neuritis CIS, reducing the need for OCB analysis. In optic neuritis, OCB assessment alone or in conjunction with a kappa index cut-off of 15 offered the best diagnostic accuracy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1771566","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:23:35Z","timestamp":1787631815000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Kappa index: real-world study for assessing cut-off values that provide the best accuracy for multiple sclerosis diagnosis in patients with CIS"],"prefix":"10.3389","volume":"17","author":[{"given":"Jos\u00e9 Luis","family":"Veiga-Gonz\u00e1lez","sequence":"first","affiliation":[{"name":"Department of Immunology, Hospital Universitario Ram\u00f3n y Cajal, Red Espa\u00f1ola de Esclerosis M\u00faltiple (REEM), Red de Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III (ISCIII), Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Monreal","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitario Ram\u00f3n y Cajal, Red Espa\u00f1ola de Esclerosis M\u00faltiple (RE-EM), Red de Enfermedades Inflamatorias (REI), ISCIII, IRYCIS","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Espi\u00f1o","sequence":"additional","affiliation":[{"name":"Department of Immunology, Hospital Universitario Ram\u00f3n y Cajal, Red Espa\u00f1ola de Esclerosis M\u00faltiple (REEM), Red de Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III (ISCIII), Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Chico-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitario Ram\u00f3n y Cajal, Red Espa\u00f1ola de Esclerosis M\u00faltiple (RE-EM), Red de Enfermedades Inflamatorias (REI), ISCIII, IRYCIS","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Fern\u00e1ndez-Velasco","sequence":"additional","affiliation":[{"name":"Department of Immunology, Hospital Universitario Ram\u00f3n y Cajal, Red Espa\u00f1ola de Esclerosis M\u00faltiple (REEM), Red de Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III (ISCIII), Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rodr\u00edguez-Jorge","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitario Ram\u00f3n y Cajal, Red Espa\u00f1ola de Esclerosis M\u00faltiple (RE-EM), Red de Enfermedades Inflamatorias (REI), ISCIII, IRYCIS","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Villarrubia","sequence":"additional","affiliation":[{"name":"Department of Immunology, Hospital Universitario Ram\u00f3n y Cajal, Red Espa\u00f1ola de Esclerosis M\u00faltiple (REEM), Red de Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III (ISCIII), Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rodero-Romero","sequence":"additional","affiliation":[{"name":"Department of Immunology, Hospital Universitario Ram\u00f3n y Cajal, Red Espa\u00f1ola de Esclerosis M\u00faltiple (REEM), Red de Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III (ISCIII), Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Sainz de la Maza","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitario Ram\u00f3n y Cajal, Red Espa\u00f1ola de Esclerosis M\u00faltiple (RE-EM), Red de Enfermedades Inflamatorias (REI), ISCIII, IRYCIS","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Masjuan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitario Ram\u00f3n y Cajal, Red Espa\u00f1ola de Esclerosis M\u00faltiple (RE-EM), Red de Enfermedades Inflamatorias (REI), ISCIII, IRYCIS","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucienne","family":"Costa-Frossard","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitario Ram\u00f3n y Cajal, Red Espa\u00f1ola de Esclerosis M\u00faltiple (RE-EM), Red de Enfermedades Inflamatorias (REI), ISCIII, IRYCIS","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa Mar\u00eda","family":"Villar","sequence":"additional","affiliation":[{"name":"Department of Immunology, Hospital Universitario Ram\u00f3n y Cajal, Red Espa\u00f1ola de Esclerosis M\u00faltiple (REEM), Red de Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III (ISCIII), Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: A review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00188","article-title":"Impact of the McDonald criteria 2017 on early diagnosis of relapsing-remitting multiple sclerosis","volume":"10","author":"Schwenkenbecher","year":"2019","journal-title":"Front Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000699","article-title":"Diagnosis of multiple sclerosis: Revisions of the McDonald criteria 2017 - continuity and change","volume":"32","author":"Hartung","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-304695","article-title":"Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: A meta-analysis of prevalence, prognosis and effect of latitude","volume":"84","author":"Dobson","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac220","article-title":"The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria","volume":"145","author":"Arrambide","year":"2022","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acc.2022.03.004","article-title":"Oligoclonal bands: An immunological and clinical approach","volume":"109","author":"Cabrera","year":"2022","journal-title":"Adv Clin Chem"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/00045632231179618","article-title":"The diagnostic utility of IgG index and oligoclonal bands for multiple sclerosis in a neurology hospital patient population","volume":"60","author":"Shaw","year":"2023","journal-title":"Ann Clin Biochem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/13524585221134213","article-title":"Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis","volume":"29","author":"Hegen","year":"2023","journal-title":"Mult Scler"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.07.007","article-title":"High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis","volume":"413","author":"Villar","year":"2012","journal-title":"Clin Chim Acta"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143375","article-title":"Diagnostic and prognostic value of the cerebrospinal fluid concentration of immunoglobulin free light chains in clinically isolated syndrome with conversion to multiple sclerosis","volume":"10","author":"Makshakov","year":"2015","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.07.027","article-title":"Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams","volume":"497","author":"Reiber","year":"2019","journal-title":"Clin Chim Acta"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166556","article-title":"Assessment of intrathecal free light chain synthesis: Comparison of different quantitative methods with the detection of oligoclonal free light chains by isoelectric focusing and affinity-mediated immunoblotting","volume":"11","author":"Zeman","year":"2016","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12040475","article-title":"Kappa free light chains in cerebrospinal fluid in inflammatory and non-inflammatory neurological diseases","volume":"12","author":"Konen","year":"2022","journal-title":"Brain Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/13524585221134217","article-title":"Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement","volume":"29","author":"Hegen","year":"2023","journal-title":"Mult Scler"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1288169","article-title":"Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis","volume":"14","author":"Monreal","year":"2023","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.1481","article-title":"Prognostic factors for multiple sclerosis symptoms in radiologically isolated syndrome","volume":"82","author":"Fissolo","year":"2025","journal-title":"JAMA Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113056","article-title":"The increasing role of kappa free light chains in the diagnosis of multiple sclerosis","volume":"10","author":"Konen","year":"2021","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01385","article-title":"Autoantibody diagnostics in neuroimmunology: Experience from the 2018 Italian Neuroimmunology Association External Quality Assessment Program","volume":"10","author":"Gastaldi","year":"2020","journal-title":"Front Neurol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15500","article-title":"Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigation","volume":"159","author":"Rosenstein","year":"2021","journal-title":"J Neurochem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12030720","article-title":"Decreased intrathecal concentrations of free light chains kappa in multiple sclerosis patients taking very high effective disease-modifying treatment","volume":"12","author":"S\u00fc\u00dfe","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s42466-025-00419-7","article-title":"Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab","volume":"7","author":"Konen","year":"2025","journal-title":"Neurol Res Pract"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040842","article-title":"The impact of immunomodulatory treatment on kappa free light chains as biomarker in neuroinflammation","volume":"9","author":"Konen","year":"2020","journal-title":"Cells"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.4.574","article-title":"Early differential diagnosis of multiple sclerosis using a new oligoclonal band test","volume":"62","author":"Villar","year":"2005","journal-title":"Arch Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70411","article-title":"Optimized kappa-index test protocol to detect intrathecal immunoglobulin synthesis in multiple sclerosis","volume":"32","author":"Bj\u00f6rklund","year":"2025","journal-title":"Eur J Neurol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1806398","article-title":"Kappa free light chains in cerebrospinal fluid to detect inflammation - results from a multicentric prospective real-world study","volume":"17","author":"S\u00fc\u00dfe","year":"2026","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics9040194","article-title":"Reiber's diagram for kappa free light chains: The new standard for assessing intrathecal synthesis","volume":"9","author":"Schwenkenbecher","year":"2019","journal-title":"Diagnostics (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105905","article-title":"Positive cerebrospinal fluid in the 2024 McDonald criteria for multiple sclerosis","volume":"120","author":"Deisenhammer","year":"2025","journal-title":"EBioMedicine"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103765","article-title":"Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers","volume":"24","author":"Konen","year":"2025","journal-title":"Autoimmun Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200451","article-title":"KFLC to total CSF protein ratio is an alternative to KI to diagnose multiple sclerosis: A retrospective study of 814 cases","volume":"12","author":"Moschetti","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqx037","article-title":"Performance evaluation of serum free light chain analysis: Nephelometry vs turbidimetry, monoclonal vs polyclonal reagents","volume":"147","author":"Messiaen","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000198253.35119.83","article-title":"Clinically isolated syndromes: A new oligoclonal band test accurately predicts conversion to MS","volume":"66","author":"Masjuan","year":"2006","journal-title":"Neurology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200049","article-title":"Kappa free light chain biomarkers are efficient for the diagnosis of multiple sclerosis: A large multicenter cohort study","volume":"10","author":"Levraut","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200386","article-title":"Diagnostic utility of kappa free light chain index in adults with inaugural optic neuritis","volume":"12","author":"Demortiere","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"28319","DOI":"10.1038\/s41598-025-13367-8","article-title":"Pilot study of cerebrospinal fluid biomarkers reveals inflammatory changes in patients with paranoid schizophrenia","volume":"15","author":"Konen","year":"2025","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2025.115858","article-title":"Serum and cerebrospinal kappa free light chains in psychiatric syndromes with neuronal and paraneoplastic autoantibodies","volume":"496","author":"Groeger","year":"2026","journal-title":"Behav Brain Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1177\/13524585251399102","article-title":"Optimizing kappa free light chain index thresholds for multiple sclerosis (MS) diagnosis in low-MS prevalence regions: Insights from an Asian cohort","volume":"32","author":"Kim","year":"2026","journal-title":"Mult Scler"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13553","article-title":"Clinical usefulness of prognostic biomarkers in optic neuritis","volume":"25","author":"Tejeda-Velarde","year":"2018","journal-title":"Eur J Neurol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/11795735211042166","article-title":"The influence of renal function impairment on kappa free light chains in cerebrospinal fluid","volume":"13","author":"Konen","year":"2021","journal-title":"J Cent Nerv Syst Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-1468","article-title":"Implications of monoclonal gammopathy and isoelectric focusing pattern 5 on the free light chain kappa diagnostics in cerebrospinal fluid","volume":"63","author":"Hannich","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209677","article-title":"Value of optic nerve MRI in multiple sclerosis clinical management: A MAGNIMS position paper and future perspectives","volume":"103","author":"Sastre-Garriga","year":"2024","journal-title":"Neurology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207805","article-title":"Adding the optic nerve in multiple sclerosis diagnostic criteria: A longitudinal, prospective, multicenter study","volume":"102","author":"Vidal-Jordana","year":"2024","journal-title":"Neurology"},{"key":"B46","volume-title":"A Study to Evaluate the Efficacy and Safety of BIIB091 in Participants With Relapsing Multiple Sclerosis","year":"2024"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1771566\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:23:37Z","timestamp":1787631817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1771566\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2026.1771566"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1771566","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1771566"}}